Michael Ciesielski, PhD of Roswell Park Cancer Institute discusses the impact his clinical trial has on clinicians and future research. He states that if they continue to build more data, then the study could potentionally predict when a patient may recur. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Data Could Predict When a Patient May Recur
